United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 2 minute read Pharma Industry News Novavax’s 2024-2025 COVID-19 Vaccine Receives EUA for Use in the U.S. Novavax, Inc. (Nasdaq: NVAX), a leading company in protein-based vaccines, has announced that its latest COVID-19 vaccine, the… byPallavi MadhirajuSeptember 1, 2024